Optiver Holding
LKFT

Optiver Holding’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Optiver Holding’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,535
Closed -$796K – 2894
2026
Q1 		$796K Buy
+26,535
New +$879K ﹤0.01% 582
2025
Q3 		– Sell
-78,929
Closed -$2.21M – 2773
2025
Q2 		$2.21M Buy
78,929
+48,521
+160% +$1.3M ﹤0.01% 267
2025
Q1 		$764K Buy
+30,408
New +$768K ﹤0.01% 311
2024
Q4 		– Sell
-69,396
Closed -$2M – 1097
2024
Q3 		$2M Buy
69,396
+61,448
+773% +$1.67M ﹤0.01% 355
2024
Q2 		$197K Buy
7,948
+5,912
+290% +$168K ﹤0.01% 491
2024
Q1 		$65.6K Sell
2,036
-47,924
-96% -$1.78M ﹤0.01% 531
2023
Q4 		$2.03M Buy
+49,960
New +$1.84M ﹤0.01% 347
2023
Q2 		– Sell
-2,246
Closed -$91.6K – 522
2023
Q1 		$86.8K Sell
2,246
-34,460
-94% -$1.42M ﹤0.01% 415
2022
Q4 		$1.63M Sell
36,706
-67,407
-65% -$2.84M ﹤0.01% 309
2022
Q3 		$4.44M Sell
104,113
-207,440
-67% -$10.6M ﹤0.01% 209
2022
Q2 		$17.4M Buy
311,553
+300,094
+2,619% +$17.8M 0.02% 131
2022
Q1 		$711K Sell
11,459
-20,747
-64% -$1.27M ﹤0.01% 227
2021
Q4 		$1.71M Buy
32,206
+6,149
+24% +$321K ﹤0.01% 223
2021
Q3 		$1.37M Buy
26,057
+11,336
+77% +$673K ﹤0.01% 199
2021
Q2 		$1.01M Buy
+14,721
New +$1.12M ﹤0.01% 189

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Optiver Holding's LKFT Position: Q2 2026 in Review

Optiver Holding sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 26,535 shares — an estimated $796K sold.

Optiver Holding first reported a position in LKFT in Q2 2021 and held it in 15 quarters. The position peaked at $17.4M in Q2 2022. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Optiver Holding reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 26,535 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $796K.
  • Optiver Holding first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2021 and held it in 15 quarters.
  • Optiver Holding's Lakefront Biotherapeutics American Depositary Shares position peaked at $17.4M in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.